Last week, Andrew Speaker – an Atlanta, Ga., personal
injury lawyer with XDR-TB, a form of tuberculosis that is resistant to almost
all antibiotics – created a big
health scare by exposing fellow travelers to a dangerous infection. Speaker
flew from Atlanta to Paris on Air France on May 12 for his wedding and honeymoon,
then from Prague to Montreal on Czech Air on May 24 (and subsequently drove
back into the United States despite border officials having orders to detain
him). As a result, Speaker set off an ongoing international hunt for people
who may had come into contact with him during his two weeks in Europe and on
both transatlantic flights (some 80 passengers and crew members were thought
to be most at risk to exposure).
Speaker's odyssey demonstrates how ill-prepared the United States is to deal
with the potential threat of bioterrorism. Instead of being a tuberculosis patient,
imagine if Speaker had been a terrorist infected with smallpox. Smallpox is
considered a particularly serious threat because of its high fatality rate (30
percent or more of unvaccinated persons) and transmissibility – a suicide terrorist
with the smallpox virus could infect people simply by coughing and sneezing,
which can release millions of virus particles into the air.
Speaker was thought to put at least 80 people at risk to exposure to XDR-TB.
A study by the Center for Disease Control (CDC) estimated that a smallpox victim
would infect about three other people before authorities could administer vaccinations
and implement other countermeasures (one of the problems with smallpox is that
the initial symptoms are flu-like and thus not likely to be correctly diagnosed
as smallpox immediately, so there would be a lag of days to weeks between infection
and knowing there was an outbreak). So if Speaker had smallpox and infected
80 people, those 80 people would infect another 240, who would, in turn, infect
another 720 people, and so on (it's worth noting that a British study estimated
that a person who contracted smallpox would spread the disease to as many as
12 other people). According to the CDC estimate, if 100 people in a city of
403,000 were exposed to the smallpox virus, the result would be 4,200 smallpox
cases and it would take a year to control. But in the case of Speaker, the people
infected wouldn't necessarily all be from one city. In a highly mobile society,
the passengers on the same flights as Speaker could have been connecting to
other flights destined for a number of different cities.
Because smallpox was considered eradicated in the 1970s (the last known
case in the United States was in 1949), people are no longer routinely vaccinated
for the disease – which means the population is vulnerable if infected. But
since there is also no known effective treatment for smallpox, the only way
to protect against infection is by vaccination. However, waiting until there
is a confirmed outbreak may be too late – especially if it is an intentional
release of the smallpox virus.
Dark
Winter was an exercise conducted in June 2001 to understand the implications
(not likelihood) of a bioterrorist attack using smallpox released via aerosol
at three shopping malls in Oklahoma, Georgia, and Pennsylvania. On day one of
the fictional crisis (nine days after initial "exposure"), all that
was known was that some two dozen people reported to hospitals in Oklahoma City
with flu-like symptoms of a strange illness (there were no similar signs of
potential outbreak in Georgia and Pennsylvania, where the dispersion was not
as effective but nonetheless resulted in infected people), which was later confirmed
by CDC as smallpox. Assuming that each "victim" had infected at least
10 other people, on day six of the crisis there were 2,000 known cases of smallpox
and 300 deaths. With only 12 million doses on hand, the reserve of smallpox
vaccine was effectively used up on day six. By day 12 of the crisis, there were
3,000 cases and 1,000 dead in 25 states. With the vaccine supply exhausted,
the smallpox virus was projected to explode as follows:
After 3 weeks: 30,000 cases and 10,000 dead.
After 5 weeks: 300,000 cases and 100,000 dead.
After 7 weeks: 3 million cases and 1 million dead.
Currently, the U.S. government is stockpiling smallpox vaccine to be used
in the event of an outbreak or bioterrorist attack. A Food and Drug Administration
(FDA) panel of medical experts recently recommended
a smallpox vaccine manufactured by UK-based Acambis for approval (Acambis
has been making the vaccine for the U.S. strategic stockpile since 2001). And
the Department of Health and Human Services (HHS) just announced that it was
purchasing
20 million doses of a smallpox vaccine manufactured by Bavarian Nordic (a
Dutch pharmaceutical company) to treat people with compromised immune systems.
In both cases, however, the vaccine would not be made available to the public
(even though it is being paid for by the public).
But if the Andrew Speaker episode is any indication of the government's ability
to respond to a potential bioterror attack using a contagious pathogen, a more
effective approach than leaving the entire population at risk and responding
only in the event of an actual smallpox attack would be to make the smallpox
vaccine available to the general public for voluntary vaccination. Even if only
a fraction of the population chose to be vaccinated, there would be a community
immunity effect that would lower the rate of transmission of the disease in
the event of an outbreak or attack and significantly increase the effectiveness
of post-infection vaccination.
If the paramount obligation of the federal government is to protect the
United States and its population, when it comes to the potential threat of bioterrorism
such as smallpox, an ounce of prevention beforehand is better than hoping a
pound of cure will work after the fact.